# Cyclophosphamide, Methotrexate, and Fluorouracil Versus Tamoxifen Plus Ovarian Suppression as Adjuvant Treatment of Estrogen Receptor–Positive Pre-/Perimenopausal Breast Cancer Patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cyclophosphamide-methotrexate-and-fluorouracil-versus-tamoxifen-plus-ovarian/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Francesco Boccardo,A. Rubagotti,D. Amoroso,M. Mesiti,D Romeo,P Sismondi,M Giai,Franco Tarro Genta,P Pacini,V. Distante,Angelo Bolognesi,D. Aldrighetti,A. Farris,for the Italian Breast Cancer Adjuvant Study Group |
| Citations | 186 |
| DOI | 10.1200/jco.2000.18.14.2718 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2104828918 |
| PMID | 10894871 |
| Type | article |
| Year | 2000 |

## Paper authors

- [Angelo Bolognesi](https://scholariq.org/researchers/angelo-bolognesi/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Menopause: Health Impacts and Treatments](https://scholariq.org/topics/menopause-health-impacts-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.